Walgreen Co. has agreed to buy assets of BioScrip's specialty and mail service pharmacy businesses for $225 million.

In the deal, Walgreens is set to acquire BioScrip's network of 30 specialty pharmacy locations in 16 states and Washington, D.C., which primarily serves HIV, cancer and transplant patients. The nation's largest drugstore operator also will acquire certain assets of BioScrip's centralized specialty pharmacy business and traditional mail service pharmacy business that dispenses prescriptions for, among others, drugstore.com, which was acquired by Walgreens in June 2011.

The acquisition "creates a strong network of support for our core drugstore business to provide specialty pharmacy solutions to our patients," Walgreens President and CEO Greg Wasson said in a statement.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.